Joinstar Biomedical Technology Co., Ltd.

Joinstar Biomedical Technology Co., Ltd.

Zhejiang,China

Joinstar Biomedical Technology Co., Ltd.

Zhejiang,China

favorite supplier

verified Copper Member
Joinstar Biomedical Technology Co., Ltd.
favorite supplier

Joinstar Biomedical Technology Co., Ltd.

Zhejiang,China

Scan QR code

Access to mobile station

SARS-CoV-2 IgM/IgG Antibody Test (Colloidal Gold)

FOB Price : Get a Price/Quote

Min.Order : 10,000 Piece(s)

Certification : GMP,ISO13485,CE

Brand Name : Joinstar

Payment Terms : T/T

favorite

share :

product information

  • brand name : Joinstar

  • certification : GMP,ISO13485,CE

  • min.order : 10,000 Piece(s)

  • warranty :

  • payment terms : T/T

  • Packaging :

  • Specification :

  • place of origin : China

product description

Model: /                                                                                        Certification: CE

Dimension: /                                                                                 Packaging Details: 25 test/box, 40box/CTN

Brand Name: JOINSTAR                                                               Place of Origin: China

Warranty: N/A                                                                              Color: white

Size: /                                                                                            Finish: /

Customer's Logo: /                                                                       MOQ: 10,000test

Processing Time: /                                                                        Usage: /

Quality: /                                                                                      Packing:  /

Features & Benefits

Relative Sensitivity: 88.89%. Relative Specificity: 100.00%. Accuracy: 91.07%
Colloidal gold immunochromatography
Results in 15 minutes
For use with human whole blood, plasma and serum
Simultaneous detection of IgM and IgG antibodies thereby minimizing risk of missed detection
No equipment needed, suitable for on-site screening   
It is widely accepted  that IgM provides the first line of defense during viral infection,followed by the generation of adaptive,high affinity IgG responses for long term immunity and immunological memory. Therefore testing of SARS-CoV-2 IgM and IgG antibodies is an effective method for the rapid diagnosis of SARS-CoV-2 infection. Furthermore, detection of SARS-CoV-2 IgM antibodies is indicative of a recent exposure to SARS-Cov-2, whereas detection of SARS-CoV-2 IgG antibodies indicates a later stage of infection. Therefore this combined antibody test could provide indicative information on the stage of infection as well.

Joinstar Biomedical Technology Co., Ltd.

Copper verified

Business Type Manufacturer

Country / Region Zhejiang,China

Main Products Reagents & Chemicals

Main Markets GLOBAL

SARS-CoV-2 IgM/IgG Antibody Test (Colloidal Gold)
share :

product information

product description

Model: /                                                                                        Certification: CE

Dimension: /                                                                                 Packaging Details: 25 test/box, 40box/CTN

Brand Name: JOINSTAR                                                               Place of Origin: China

Warranty: N/A                                                                              Color: white

Size: /                                                                                            Finish: /

Customer's Logo: /                                                                       MOQ: 10,000test

Processing Time: /                                                                        Usage: /

Quality: /                                                                                      Packing:  /

Features & Benefits

Relative Sensitivity: 88.89%. Relative Specificity: 100.00%. Accuracy: 91.07%
Colloidal gold immunochromatography
Results in 15 minutes
For use with human whole blood, plasma and serum
Simultaneous detection of IgM and IgG antibodies thereby minimizing risk of missed detection
No equipment needed, suitable for on-site screening   
It is widely accepted  that IgM provides the first line of defense during viral infection,followed by the generation of adaptive,high affinity IgG responses for long term immunity and immunological memory. Therefore testing of SARS-CoV-2 IgM and IgG antibodies is an effective method for the rapid diagnosis of SARS-CoV-2 infection. Furthermore, detection of SARS-CoV-2 IgM antibodies is indicative of a recent exposure to SARS-Cov-2, whereas detection of SARS-CoV-2 IgG antibodies indicates a later stage of infection. Therefore this combined antibody test could provide indicative information on the stage of infection as well.

Recommend